Financhill
Sell
46

NAMS Quote, Financials, Valuation and Earnings

Last price:
$25.50
Seasonality move :
43.24%
Day range:
$24.55 - $26.25
52-week range:
$10.50 - $27.29
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
68.38x
P/B ratio:
6.22x
Volume:
1M
Avg. volume:
1.2M
1-year change:
142.86%
Market cap:
$2.4B
Revenue:
$14.1M
EPS (TTM):
-$2.25
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue -- -- -- $102.7M $14.1M
Revenue Growth (YoY) -- -- -- -- -86.28%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- $5M $29M $86.7M $159.4M
Selling, General & Admin -- $1.5M $5.7M $14M $29.8M
Other Inc / (Exp) -- $29.5K -$6.4M -$18.8M -$5.2M
Operating Expenses -- $6.5M $34.7M $100.8M $189.2M
Operating Income -- -$6.5M -$34.7M $1.9M -$175.1M
 
Net Interest Expenses -- -- -- $5.8M --
EBT. Incl. Unusual Items -- -$7.1M -$41.8M -$22.6M -$176.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- $27K
Net Income to Company -- -$7.1M -$41.8M -$22.6M -$176.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -$7.1M -$41.8M -$22.6M -$176.9M
 
Basic EPS (Cont. Ops) -- -$0.09 -$0.51 -$1.19 -$2.15
Diluted EPS (Cont. Ops) -- -$0.09 -$0.51 -$1.19 -$2.15
Weighted Average Basic Share -- $81.6M $81.6M $19M $82.2M
Weighted Average Diluted Share -- $81.6M $81.6M $19M $82.2M
 
EBITDA -- -$6.6M -$41.4M -$22.3M -$176.9M
EBIT -- -$6.6M -$41.4M -$22.3M -$176.9M
 
Revenue (Reported) -- -- -- $102.7M $14.1M
Operating Income (Reported) -- -$6.5M -$34.7M $1.9M -$175.1M
Operating Income (Adjusted) -- -$6.6M -$41.4M -$22.3M -$176.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- $2.9M $29.1M
Revenue Growth (YoY) -- -- -- -- 889.83%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- $43.4M $35.7M
Selling, General & Admin -- -- -- $7.9M $17.3M
Other Inc / (Exp) -- -- -- -$634K $3.9M
Operating Expenses -- -- -- $51.2M $53M
Operating Income -- -- -- -$48.3M -$23.9M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -$47.1M -$16.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- -$1K
Net Income to Company -- -- -- -$47.1M -$16.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -$47.1M -$16.6M
 
Basic EPS (Cont. Ops) -- -- -- -$0.57 -$0.18
Diluted EPS (Cont. Ops) -- -- -- -$0.57 -$0.18
Weighted Average Basic Share -- -- -- $82.5M $94.8M
Weighted Average Diluted Share -- -- -- $82.5M $94.8M
 
EBITDA -- -- -- -$48.3M -$23.8M
EBIT -- -- -- -$48.3M -$23.9M
 
Revenue (Reported) -- -- -- $2.9M $29.1M
Operating Income (Reported) -- -- -- -$48.3M -$23.9M
Operating Income (Adjusted) -- -- -- -$48.3M -$23.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- -- $33.6M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- $157.8M
Selling, General & Admin -- -- -- -- $54.8M
Other Inc / (Exp) -- -- -- -$4.2M -$29.8M
Operating Expenses -- -- -- -- $212.6M
Operating Income -- -- -- -- -$179.1M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- -$198.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- $26K
Net Income to Company -- -- -- -- -$198.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- -$198.9M
 
Basic EPS (Cont. Ops) -- -- -- -- -$2.25
Diluted EPS (Cont. Ops) -- -- -- -- -$2.25
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- -$180.8M
EBIT -- -- -- -- -$180.9M
 
Revenue (Reported) -- -- -- -- $33.6M
Operating Income (Reported) -- -- -- -- -$179.1M
Operating Income (Adjusted) -- -- -- -- -$180.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- $13.3M $32.8M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- $118.1M $116.5M
Selling, General & Admin -- -- -- $21.1M $46.1M
Other Inc / (Exp) -- -- -- -$4.2M -$28.8M
Operating Expenses -- -- -- $139.2M $162.6M
Operating Income -- -- -- -$125.9M -$129.9M
 
Net Interest Expenses -- -- -- $282K --
EBT. Incl. Unusual Items -- -- -- -$127.4M -$149.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- -$1K
Net Income to Company -- -- -- -$127.4M -$149.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -$127.4M -$149.4M
 
Basic EPS (Cont. Ops) -- -- -- -$1.55 -$1.65
Diluted EPS (Cont. Ops) -- -- -- -$1.55 -$1.65
Weighted Average Basic Share -- -- -- $246.2M $277.8M
Weighted Average Diluted Share -- -- -- $246.2M $277.8M
 
EBITDA -- -- -- -$125.9M -$129.8M
EBIT -- -- -- -$125.9M -$129.9M
 
Revenue (Reported) -- -- -- $13.3M $32.8M
Operating Income (Reported) -- -- -- -$125.9M -$129.9M
Operating Income (Adjusted) -- -- -- -$125.9M -$129.9M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents -- $9.7M $60.1M $467.7M $340.5M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- $1.7M $8.2M $4.5M
Other Current Assets -- -- -- -- --
Total Current Assets -- $11.3M $66.7M $478M $346.8M
 
Property Plant And Equipment -- $14.8K $215.1K $154K $101K
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets -- $11.4M $67.7M $478.5M $347.1M
 
Accounts Payable -- $487.1K $7M $11.9M $16.9M
Accrued Expenses -- $937.2K $424.6K $4.1M $8M
Current Portion Of Long-Term Debt -- $14.3M -- -- --
Current Portion Of Capital Lease Obligations -- -- $60K $66K $60K
Other Current Liabilities -- -- $1.1K $4.1M $12.6M
Total Current Liabilities -- $15.8M $11.2M $36.1M $49.9M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities -- $15.8M $11.3M $48.4M $58.7M
 
Common Stock -- $3.1M $95M $10.1M $10.2M
Other Common Equity Adj -- -- $669.1K -- --
Common Equity -- -$4.4M $56.4M $430.1M $288.4M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -$4.4M $56.4M $430.1M $288.4M
 
Total Liabilities and Equity -- $11.4M $67.7M $478.5M $347.1M
Cash and Short Terms -- $9.7M $60.1M $467.7M $340.5M
Total Debt -- -- -- -- --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents -- -- -- -- $422.7M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- $10M
Other Current Assets -- -- -- -- --
Total Current Assets -- -- -- -- $437.9M
 
Property Plant And Equipment -- -- -- -- $724K
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets -- -- -- -- $439.2M
 
Accounts Payable -- -- -- -- $7M
Accrued Expenses -- -- -- -- $6.4M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- $240K
Other Current Liabilities -- -- -- -- $18.9M
Total Current Liabilities -- -- -- -- $41.3M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities -- -- -- -- $60.3M
 
Common Stock -- -- -- -- $11.4M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- -- -- $378.9M
 
Total Liabilities and Equity -- -- -- -- $439.2M
Cash and Short Terms -- -- -- -- $422.7M
Total Debt -- -- -- -- --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -- -$7.1M -$41.8M -$22.6M -$176.9M
Depreciation & Amoritzation -- $1.2K $5K $9K $49K
Stock-Based Compensation -- -- $1.2M $4.1M $24.6M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -$7.3M -$29.5M $10.7M -$141.2M
 
Capital Expenditures -- -- -- $221K $24K
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -$16K -$24K -$221K -$24K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- $13.9M -- $747K --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -$5.8M --
Cash From Financing -- $13.9M $84.7M $391.9M $8.9M
 
Beginning Cash (CF) -- $3.1M $9.6M $60.1M $467.7M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- $6.6M $55.2M $402.3M -$132.3M
Ending Cash (CF) -- $9.7M $60.1M $467.7M $340.5M
 
Levered Free Cash Flow -- -$7.4M -$29.5M $10.4M -$141.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -$47.1M -$16.6M
Depreciation & Amoritzation -- -- -- $14K $28K
Stock-Based Compensation -- -- -- $5.4M $8M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -$47M -$12.5M
 
Capital Expenditures -- -- -- $9K $75K
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -$9K -$75K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- $186K $58K
 
Beginning Cash (CF) -- -- -- $416.7M $430.7M
Foreign Exchange Rate Adjustment -- -- -- -$1.6M $4.5M
Additions / Reductions -- -- -- -$46.8M -$12.5M
Ending Cash (CF) -- -- -- $368.3M $422.7M
 
Levered Free Cash Flow -- -- -- -$47M -$12.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -- -$198.9M
Depreciation & Amoritzation -- -- -- -- $75K
Stock-Based Compensation -- -- -- $18.6M $30.2M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- -$154.2M
 
Capital Expenditures -- -- -- $21K $672K
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- -$672K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- $202.9M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- $48.1M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- -$154.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -$127.4M -$149.4M
Depreciation & Amoritzation -- -- -- $36K $62K
Stock-Based Compensation -- -- -- $18.6M $24.2M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -$108.1M -$121.1M
 
Capital Expenditures -- -- -- $21K $669K
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -$21K -$669K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- -$1.5M
Cash From Financing -- -- -- $8.9M $202.9M
 
Beginning Cash (CF) -- -- -- $1.3B $1.3B
Foreign Exchange Rate Adjustment -- -- -- -$168K $1.1M
Additions / Reductions -- -- -- -$99.3M $81.1M
Ending Cash (CF) -- -- -- $1.2B $1.3B
 
Levered Free Cash Flow -- -- -- -$108.2M -$121.8M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock